Annual Accounts Payable
$4.37 M
+$1.56 M+55.76%
December 31, 2023
Summary
- As of February 8, 2025, ELTX annual accounts payable is $4.37 million, with the most recent change of +$1.56 million (+55.76%) on December 31, 2023.
- During the last 3 years, ELTX annual accounts payable has risen by +$2.72 million (+164.64%).
- ELTX annual accounts payable is now at all-time high.
Performance
ELTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.98 M
+$929.00 K+88.06%
September 30, 2024
Summary
- As of February 8, 2025, ELTX quarterly accounts payable is $1.98 million, with the most recent change of +$929.00 thousand (+88.06%) on September 30, 2024.
- Over the past year, ELTX quarterly accounts payable has dropped by -$2.42 million (-54.97%).
- ELTX quarterly accounts payable is now -54.97% below its all-time high of $4.41 million, reached on September 30, 2023.
Performance
ELTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ELTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.8% | -55.0% |
| 3 y3 years | +164.6% | - |
| 5 y5 years | +725.1% | - |
ELTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +159.9% | -55.0% | +88.1% |
| 5 y | 5-year | at high | +725.1% | -55.0% | +88.1% |
| alltime | all time | at high | +725.1% | -55.0% | +88.1% |
Elicio Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.98 M(+88.1%) |
| Jun 2024 | - | $1.05 M(-4.5%) |
| Mar 2024 | - | $1.10 M(-74.7%) |
| Dec 2023 | $4.37 M | $4.37 M(-0.8%) |
| Sep 2023 | - | $4.41 M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $4.26 M(+52.0%) |
| Dec 2022 | $2.81 M(+66.9%) | $2.81 M(+15.5%) |
| Dec 2021 | $1.68 M(+1.8%) | - |
| Mar 2021 | - | $2.43 M |
| Dec 2020 | $1.65 M(+211.8%) | - |
| Dec 2019 | $529.50 K | - |
FAQ
- What is Elicio Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Elicio Therapeutics?
- What is Elicio Therapeutics annual accounts payable year-on-year change?
- What is Elicio Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Elicio Therapeutics?
- What is Elicio Therapeutics quarterly accounts payable year-on-year change?
What is Elicio Therapeutics annual accounts payable?
The current annual accounts payable of ELTX is $4.37 M
What is the all time high annual accounts payable for Elicio Therapeutics?
Elicio Therapeutics all-time high annual accounts payable is $4.37 M
What is Elicio Therapeutics annual accounts payable year-on-year change?
Over the past year, ELTX annual accounts payable has changed by +$1.56 M (+55.76%)
What is Elicio Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ELTX is $1.98 M
What is the all time high quarterly accounts payable for Elicio Therapeutics?
Elicio Therapeutics all-time high quarterly accounts payable is $4.41 M
What is Elicio Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ELTX quarterly accounts payable has changed by -$2.42 M (-54.97%)